In a 65-year-old woman with hypertension, type 2 diabetes mellitus, atrial fibrillation on lisinopril, metformin, and atorvastatin, and a normal CBC, who has worsening restless‑legs symptoms at night, which laboratory test should be obtained first: serum ferritin (with iron studies), vitamin B12, thyroid‑stimulating hormone (TSH), or vitamin D level?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Serum Ferritin Should Be Obtained First

In this 65-year-old woman with classic restless legs syndrome (RLS) symptoms, serum ferritin with iron studies is the single most important laboratory test to obtain. 1

Rationale for Serum Ferritin Priority

The 2025 American Academy of Sleep Medicine clinical practice guideline explicitly states that routine screening of iron indices is an essential component of RLS patient care 1. Brain iron deficiency has emerged as a leading concept in RLS pathophysiology, yet awareness of the importance of serum iron assessment remains lacking among clinicians 1.

Why Iron Testing Takes Precedence

  • Iron supplementation indices for RLS patients differ from the general adult population 1
  • Multiple recent randomized controlled trials support IV iron treatment, with ferric carboxymaltose receiving a strong recommendation 1
  • Iron deficiency must be identified and treated both to improve RLS symptoms and potentially lower the risk of augmentation (paradoxical worsening with dopaminergic treatment) 1
  • Oral iron is poorly absorbed in patients with ferritin >50-75 ng/mL, unlike IV iron 1

Why Not the Other Tests?

B12, TSH, and Vitamin D are not routinely indicated for RLS evaluation unless there are specific clinical indicators beyond the RLS symptoms themselves. The literature consistently identifies only ferritin as the routine laboratory study indicated for RLS 2. While these other tests may be relevant for evaluating peripheral neuropathy or other comorbidities, they do not directly address RLS pathophysiology or guide RLS-specific treatment.

Clinical Context Considerations

This patient has diabetes, which creates a diagnostic challenge since diabetic peripheral neuropathy can mimic RLS symptoms 3, 4. However, her symptoms meet the four essential RLS criteria:

  1. Urge to move legs with unpleasant sensations
  2. Symptoms worse at rest
  3. Relief with movement (implied by "urge to move")
  4. Nocturnal/evening predominance ("at night")

The key distinguishing feature: RLS symptoms are relieved by movement, whereas diabetic neuropathy pain typically is not 3, 4.

Important Medication Consideration

Review her current medications—statins (atorvastatin) have not been established as RLS triggers based on the provided evidence, but ensure no other medications are exacerbating symptoms 3.

Next Steps After Ferritin

If ferritin is low, iron supplementation (IV preferred for ferritin >50-75 ng/mL) should be initiated 1. If ferritin is adequate and symptoms require pharmacotherapy, alpha-2-delta ligands (gabapentin or pregabalin) are now preferred first-line agents over dopamine agonists, particularly given her diabetes where these agents also treat neuropathic pain 1, 3.

Related Questions

In a 64-year-old man with diabetes and restless legs syndrome who has nighttime leg pain despite gabapentin 100 mg at bedtime and normal iron and ferritin levels, what is the next best step in management?
In a 65-year-old female with hypertension, type 2 diabetes mellitus, and atrial fibrillation who is taking metformin and a statin, and who presents with worsening insomnia and a restless‑legs sensation at rest and at night, with normal vital signs, unremarkable physical examination, and normal complete blood count, what evaluation should be recommended for her symptoms?
How should I evaluate and manage an 88-year-old woman with leg and foot cramping that worsens at bedtime and improves with walking, consistent with restless‑leg syndrome?
How should I evaluate and manage an 18‑year‑old female with a one‑month history of bilateral lower‑leg pain and restlessness at night causing insomnia, with normal oxygen saturation, pulse, and blood pressure?
For a 60‑year‑old patient with several months of non‑restorative sleep, leg discomfort and urge to move the legs at night, and episodic involuntary leg movements during sleep, which medication—sertraline, melatonin, duloxetine, or gabapentin—is the most appropriate treatment?
What is the recommended workup and initial management for a patient presenting with a petechial rash, joint pain, and swelling?
How do I diagnose and treat palmoplantar lesions that may represent secondary syphilis mimicking psoriasis?
How should I manage a patient with metastatic cancer who has elevated creatine kinase and hyperkalemia?
What diagnostic test should be ordered to evaluate for xeroderma pigmentosum in a patient with extreme sun sensitivity and a 2% immature granulocyte percentage?
What workup and management are recommended for a 21‑year‑old male with a year‑long hard, distended abdomen, intermittent diarrhea, increased flatulence, daily bowel movements, and no nausea, vomiting, smoking, or alcohol use?
What does an immature granulocyte level of 0.5% on a complete blood count indicate?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.